Ewha Womans University's CART Rider Team for the 3rd Idea Contest of Hanall Biopharma
Sep 02, 2025
|
Since 2022, Hanall Biopharma has provided students with an opportunity to gain understanding and experience in the field of new drug development through the Pharmaceutical Student Idea Contest, with fostering talents who will lead future new drug development as its core value.
This year, under the theme of 「Proposal of New Drug Development Idea with Reverse Aging Technology」, ideas were received from pharmacological students nationwide from May 26 to June 23. Among them, the award-winning work was decided based on creativity, feasibility, and completeness after the first written evaluation and the second presentation review.
The grand prize was selected by the team 'CAR-Trider' consisting of students Park Gun-young and Jo In-kyung of Ewha Womans University. They were highly praised for incorporating partial reprogramming to overcome the limitations of CAR-T treatments in blood cancer treatment.
Song Chang-hee of Catholic University and Choi Woong-jae of Cha Medical University, who proposed a step-by-step clinical design strategy for reverse aging treatment for eyes, lungs, and muscle indications, and Kim Ji-young and Jang Mi-na of Chung-Ang University, who proposed an Alzheimer's treatment strategy using nasal spray-type reverse aging gene therapy, won the grand prize.
The target team will experience the new drug development environment on the global stage by being given the opportunity to visit the Hanall Biopharma U.S. corporation 'HPI (Hanall Pharmaceutical International)' and global bio companies and research institutes.
"It seems to have been a good opportunity to study in-depth about reverse aging technologies and drug delivery technologies (DDSs), which are currently receiving a lot of attention while preparing for the competition," said Park Geon-young, a student at Ewha Womans University. "The idea to incorporate it into CAR-T came up after a lot of thought and research to propose an idea using reverse aging technology, and I am glad that the intention was well conveyed."
Jeong Seung-won, CEO of Hanall Biopharma, said "We focus on discovering and fostering creative and viable talents who will lead the future of new drug development beyond simply selecting ideas"As the contest leads to a higher level of worries and challenges every year, we will continue to provide an environment and opportunities for talented people who will be the leaders of the future bio industry to grow."
This article was translated by Naver AI translator.
